Next Article in Journal
Optimizing Growth of the Future Liver Remnant and Making In-Situ Liver Transsection Safe—A Standardized Approach to ISLT or ALPPS
Previous Article in Journal
Descriptive Analysis of First-Line Non-Small Cell Lung Cancer Treatment with Pembrolizumab in Tumors Expressing PD-L1 ≥ 50% in Patients Treated in Quebec’s University Teaching Hospitals (DALP-First Study)
 
 
Review

Article Versions Notes

Curr. Oncol. 2023, 30(3), 3263-3276; https://doi.org/10.3390/curroncol30030248
Action Date Notes Link
article xml file uploaded 11 March 2023 09:35 CET Original file -
article xml uploaded. 11 March 2023 09:35 CET Update https://www.mdpi.com/1718-7729/30/3/248/xml
article pdf uploaded. 11 March 2023 09:35 CET Version of Record https://www.mdpi.com/1718-7729/30/3/248/pdf
article html file updated 11 March 2023 09:36 CET Original file -
article html file updated 20 March 2023 22:32 CET Update https://www.mdpi.com/1718-7729/30/3/248/html
Back to TopTop